These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 19380227)

  • 1. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
    Weihl CC; Pestronk A; Kimonis VE
    Neuromuscul Disord; 2009 May; 19(5):308-15. PubMed ID: 19380227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
    Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
    J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy.
    Guinto JB; Ritson GP; Taylor JP; Forman MS
    Acta Neuropathol; 2007 Jul; 114(1):55-61. PubMed ID: 17457594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis.
    Weihl CC
    Curr Alzheimer Res; 2011 May; 8(3):252-60. PubMed ID: 21222596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
    Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
    J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic variability in three families with valosin-containing protein mutation.
    Spina S; Van Laar AD; Murrell JR; Hamilton RL; Kofler JK; Epperson F; Farlow MR; Lopez OL; Quinlan J; DeKosky ST; Ghetti B
    Eur J Neurol; 2013 Feb; 20(2):251-8. PubMed ID: 22900631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
    Ju JS; Weihl CC
    Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.
    Forman MS; Mackenzie IR; Cairns NJ; Swanson E; Boyer PJ; Drachman DA; Jhaveri BS; Karlawish JH; Pestronk A; Smith TW; Tu PH; Watts GD; Markesbery WR; Smith CD; Kimonis VE
    J Neuropathol Exp Neurol; 2006 Jun; 65(6):571-81. PubMed ID: 16783167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
    Ching JK; Elizabeth SV; Ju JS; Lusk C; Pittman SK; Weihl CC
    Hum Mol Genet; 2013 Mar; 22(6):1167-79. PubMed ID: 23250913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
    Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
    PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
    Weihl CC; Miller SE; Hanson PI; Pestronk A
    Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
    Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
    Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.
    Neumann M; Mackenzie IR; Cairns NJ; Boyer PJ; Markesbery WR; Smith CD; Taylor JP; Kretzschmar HA; Kimonis VE; Forman MS
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):152-7. PubMed ID: 17279000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
    Tresse E; Salomons FA; Vesa J; Bott LC; Kimonis V; Yao TP; Dantuma NP; Taylor JP
    Autophagy; 2010 Feb; 6(2):217-27. PubMed ID: 20104022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valosin-containing protein gene mutations: clinical and neuropathologic features.
    Guyant-Maréchal L; Laquerrière A; Duyckaerts C; Dumanchin C; Bou J; Dugny F; Le Ber I; Frébourg T; Hannequin D; Campion D
    Neurology; 2006 Aug; 67(4):644-51. PubMed ID: 16790606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia.
    Stojkovic T; Hammouda el H; Richard P; López de Munain A; Ruiz-Martinez J; Camaño P; Laforêt P; Pénisson-Besnier I; Ferrer X; Lacour A; Lacomblez L; Claeys KG; Maurage CA; Fardeau M; Eymard B
    Neuromuscul Disord; 2009 May; 19(5):316-23. PubMed ID: 19364651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling.
    Viassolo V; Previtali SC; Schiatti E; Magnani G; Minetti C; Zara F; Grasso M; Dagna-Bricarelli F; Di Maria E
    Clin Genet; 2008 Jul; 74(1):54-60. PubMed ID: 18341608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.
    Watts GD; Thomasova D; Ramdeen SK; Fulchiero EC; Mehta SG; Drachman DA; Weihl CC; Jamrozik Z; Kwiecinski H; Kaminska A; Kimonis VE
    Clin Genet; 2007 Nov; 72(5):420-6. PubMed ID: 17935506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.